Drug intelligence / Profile preview

Influvax Tetra

Development stage
Unknown
Lead developer
Incepta Pharmaceuticals
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

**Influvax Tetra** is an egg-derived, inactivated split-virion quadrivalent seasonal influenza vaccine manufactured by Incepta Pharmaceuticals for prevention of influenza in adults and children aged 6 months and older. Each 0.5 mL dose contains 15 micrograms of hemagglutinin from two influenza A strains and two influenza B lineage strains. The viruses are propagated in specific-pathogen-free chicken eggs, split, and inactivated with formaldehyde. Vaccination induces strain-directed humoral immune responses, including neutralizing antibodies against influenza viral surface antigens, to reduce the risk of influenza infection. ([inceptavaccine.com](https://inceptavaccine.com/pdf/1676530325_pdoc_INFLUVAX%20TETRA%20LEAFLET%20FOR%20WEB.pdf))

Brand names
Influvax Tetra
02

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on Influvax Tetra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influvax Tetra.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call